About: Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Bertucci François, Fekih Mahmoud, Autret Aurélie, Petit Thierry, Dalenc Florence, Levy Christelle, Romieu Gilles, Bonneterre Jacques, Ferrero Jean-Marc, Kerbrat Pierre, Soulie Patrick, Mouret-Reynier Marie-Ange, Bachelot Thomas, Lerebours Florence, Eymard Jean-Christophe, Deblock Mathilde, Lortholary Alain, Hardy-Bessard Anne-Claire, Barthelemy Philippe, Bonnefoi Hervé, Charafe-Jauffret Emmanuelle, Bidard François-Clément, Viens Patrice, Lemonnier Jérôme, Pierga Jean-Yves . Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study . Lancet Oncology, 2016, 17 (5), pp.600-611 . ⟨10.1016/s1470-2045(16)00011-5⟩
Title
  • Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study
dc:date
  • 2016
Digital Object Identifier (DOI)
  • 10.1016/s1470-2045(16)00011-5
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software